$BIIB News U.S. stocks rise; SP 500 positive for the year

New Post Public Reply Private Reply Replies (0) Message Board

Mar 18, 2014 at 11:38 AM

$BIIB News

U.S. stocks rise; S&P 500 positive for the year 4:40 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Sue Chang
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap 5:03 p.m. March 7, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 5:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 3:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 8:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 4:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 10:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 5:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 1:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 1:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 3:33 p.m. Dec. 10, 2013 - The Trading Deck

The Move Down In Berry Plastics Is Half Over From My Perspective 9:40 a.m. Today - Seeking Alpha
FDA delays decision on Biogen's Plegridy MS treatment 8:42 a.m. Today - Seeking Alpha
Veteran Investor's Top Biotech and Drug Stocks 7:07 a.m. Today - Barrons.com
Stocks Rally Amid Rise in Factory Production; Lack of Ukraine Violence 4:36 p.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain, Biogen Shares Rally Following Additions to S&P Indices? 12:06 p.m. March 17, 2014 - benzinga.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 11:07 a.m. March 17, 2014 - TheStreet.com
Jim Cramer's Mad Dash: HTZ REGN 10:41 a.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain Pops on S&P 500 Invite 9:15 a.m. March 17, 2014 - FOXBusiness
American Funds: 5 Mutual Funds to Buy 4:34 a.m. March 17, 2014 - InvestorPlace.com
Cramer's Mad Money - China Is No Problem For General Electric Long-Term (3/14/14) 6:24 a.m. March 16, 2014 - Seeking Alpha
'Mad Money' Lightning Round: You Have to Own GE 6:00 a.m. March 15, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:24 p.m. March 14, 2014 - TheStreet.com
MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog 3:31 p.m. March 14, 2014 - Zacks.com
AVEO Q4 Loss Narrower than Expected - Analyst Blog 9:10 a.m. March 14, 2014 - Zacks.com
Wider Q4 Loss at Keryx - Analyst Blog 1:19 p.m. March 13, 2014 - Zacks.com
Fate Therapeutics' Prohema in Phase II Study - Analyst Blog 11:50 a.m. March 13, 2014 - Zacks.com
Myriad Genetics Down on Court Ruling - Analyst Blog 3:30 p.m. March 12, 2014 - Zacks.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN) 9:01 a.m. March 12, 2014 - benzinga.com
Gilead Sciences' Novel Leukemia Drug Should Extend Company Profits 4:47 p.m. March 11, 2014 - Seeking Alpha

Biogen Idec Receives Notification of PDUFA Date Extension for Plegridy™(Peginterferon Beta-1a) 7:30 a.m. Today - BusinessWire - BZX
Biogen Idec Set to Join the S&P 100; Keurig Green Mountain to Join the S&P 500; Changes to the S&P MidCap 400 and the S&P SmallCap 600 5:58 p.m. March 14, 2014 - PR Newswire - PRF
Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories 8:00 a.m. March 12, 2014 - PR Newswire - PRF
RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry 5:00 a.m. March 6, 2014 - BusinessWire - BZX
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...